Windlas Biotech Ltd. IPO

It is among the top 5 companies in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry.

RHP
View
DRHP
View
Open Date

2021-08-04

Close Date

2021-08-06

Company Financials

You can get the following financial statements of Windlas Biotech Ltd. as of now.

Subscription Details

The valuation of Windlas Biotech IPO company based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 460
Existing Shares (Qty) 1.82 Cr
Fresh Issue (Qty)  0.36 Cr
Market Cap ~1003 Cr
EPS  Rs 8.7 
PE Ratio ~53x
Industry PE ~13x

 

Windlas Biotech IPO issue size is 401.54 Cr

Issue Amount
Fresh Issue 165 Cr
Offer For Sale 236.54 Cr

 

An Individual can apply for a minimum 1 lot of 30 shares and a maximum of 14 lots of 420 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 30 Rs 13,800
 Maximum 14 420 Rs 1,93,200

 

Windlas Biotech IPO is subscribed 22.44 times till 6th August. It is Oversubscribed as of now. The category-wise subscription is as follows:

Category % Offered Subscription 
Qualified Institutional Maximum 50% 24.40 Times
Non-Institutional Minimum 15% 15.73 Times
Retail Individual Minimum 35% 24.22 Times
Total   22.44 Times

Allotment Details

Once you have subscribed to an IPO, you have to wait for its allotment to your account. Find below the dates of allotment of Windlas Biotech IPO:

Schedule Date
Basis of Allotment 11 August 2021
Refunds 12 August 2021
Credit to Demat Account 13 August 2021
IPO Listing Date 16 August 2021

 

When the allotment is out, you can check it from the registrar's website. Find the Windlas Biotech IPO allotment status here.

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 288.2 328.85 427.6 465.93 513.08
Total Expenditure 243.74 287.39 372.91 413.04 452.84
Operating Profit 44.47 41.47 54.69 52.9 60.24
Other Income 2.12 2.49 3.09 6.71 9.97
Interest 3.64 2.53 1.29 1.42 0.79
Depreciation 8.09 9.29 12.97 12.15 12.36
Exceptional Items 0 0 -32.35 0 0
Profit Before Tax 34.86 32.13 11.18 46.04 57.06
Provision for Tax 12.39 8.46 6.17 7.48 14.41
Net Profit 22.47 23.68 5.01 38.56 42.64
Adjusted EPS (Rs.) 3.51 1.3 0.28 1.77 2.04

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 6.41 6.41 6.41 10.9 10.46
Total Reserves 187.61 213.94 192.58 384.23 392.2
Borrowings 5.82 1.21 0.83 0.44 0.11
Other N/C liabilities -0.78 1.66 2.75 -0.23 3.33
Current liabilities 96.12 125.29 93.42 93.65 120.88
Total Liabilities 295.17 348.52 295.99 488.99 526.98
Assets
Net Block 61.93 70.26 95.94 91.18 109.41
Capital WIP 4.58 0 0.04 7.58 13.8
Intangible WIP 0 0 0 0.43 0.98
Investments 104.69 104.69 0.03 0.03 0.03
Loans & Advances 7.6 5.4 5.84 5.39 43.31
Other N/C Assets 0 0.13 0 2.73 5.92
Current Assets 116.38 168.03 194.15 381.63 353.54
Total Assets 295.17 348.52 295.99 488.99 526.98
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Other Income 2.16 2.33 2.62 3.24 3.16
Profit Before Tax 12.82 15.05 16.34 18.31 19.81
Tax 3.63 3.6 4.28 4.28 4.71
Profit After Tax 9.19 11.45 12.07 14.03 15.1
Adjusted EPS (Rs) 4.29 5.47 5.8 6.75 7.26

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 62.82 0
Sep 2023 62.82 0
Jun 2023 62.82 0
Mar 2023 62.38 0
Dec 2022 60.75 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 34.86 32.13 11.18 46.04 57.06
Adjustment 9.87 9.77 46.85 9.75 7.35
Changes in Assets & Liabilities -9.28 -3.53 -40.05 -37.91 6.29
Tax Paid -13.37 -13.46 -6.53 -8.88 -9.72
Operating Cash Flow 22.08 24.91 11.45 9 60.98
Investing Cash Flow -6.59 -14.25 -14.53 -154.31 -14.11
Financing Cash Flow -7.85 -5.44 0.78 130.09 -43.74
Net Cash Flow 7.64 5.22 -2.3 -15.22 3.13
X